ODULIMOMAB
UNII 39R9XU694M

Substance Identification & Data

This profile provides standardized clinical and technical data for Odulimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 39R9XU694M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 159445-64-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

39R9XU694M

CAS Registry Number

159445-64-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ODULIMOMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188506

National Cancer Institute reference terminology for clinical and research data.

INN ID

7364

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Odulimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ODULIMOMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11 (ANTIGEN) .ALPHA.-CHAIN) (MOUSE MONOCLONAL 25.3 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL 25.3 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11 (ANTIGEN) A-CHAIN) (MOUSE MONOCLONAL 25.3 G1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL 25.3 LIGHT CHAIN, DIMER

ODULIMOMAB [INN]